The Role of Branch Cell Symmetry and Other Critical Nanoscale Design Parameters in the Determination of Dendrimer Encapsulation Properties

Abstract

This article reviews progress over the past three decades related to the role of dendrimer-based, branch cell symmetry in the development of advanced drug delivery systems, aqueous based compatibilizers/solubilizers/excipients and nano-metal cluster catalysts. Historically, it begins with early unreported work by the Tomalia Group (i.e., The Dow Chemical Co.) revealing that all known dendrimer family types may be divided into two major symmetry categories; namely: Category I: symmetrical branch cell dendrimers (e.g., Tomalia, Vögtle, Newkome-type dendrimers) possessing interior hollowness/porosity and Category II: asymmetrical branch cell dendrimers (e.g., Denkewalter-type) possessing no interior void space. These two branch cell symmetry features were shown to be pivotal in directing internal packing modes; thereby, differentiating key dendrimer properties such as densities, refractive indices and interior porosities. Furthermore, this discovery provided an explanation for unimolecular micelle encapsulation (UME) behavior observed exclusively for Category I, but not for Category II. This account surveys early experiments confirming the inextricable influence of dendrimer branch cell symmetry on interior packing properties, first examples of Category (I) based UME behavior, nuclear magnetic resonance (NMR) protocols for systematic encapsulation characterization, application of these principles to the solubilization of active approved drugs, engineering dendrimer critical nanoscale design parameters (CNDPs) for optimized properties and concluding with high optimism for the anticipated role of dendrimer-based solubilization principles in emerging new life science, drug delivery and nanomedical applications.

Neuroinflammation Treatment via Targeted Delivery of Nanoparticles

“…Overcoming these issues, polymeric nanoparticles introduce control over the molecular architecture, allow precise tuning of drug release, and provide enhanced functionalization capabilities. Dendrimers, for instance, are highly branched and symmetric synthetic nanoparticles whose size, shape, and composition can be accurately controlled (Tomalia et al, 2020). Some interesting properties of dendrimers are size monodispersity, high drug payloads, diverse surface functionalization capability and molecular stability, which make them attractive drug carrier candidates.…”

The Structure of PAMAM DAB-dendr(NH2)4 – the First Crystal Structure of a PAMAM-Dendrimer

“…The Z-shape folding thus provides for a packing with no internal or external voids leading to a solvent-free structure. The absence of internal voids is contrary to the common belief that all generations of PAMAMdendrimers have internal voids 25 .…”

Non-invasive intranasal administration route directly to the brain using dendrimer nanoplatforms: An opportunity to develop new CNS drugs

“…In this direction, in a recent tutorial review, Tomalia et al. analyzed the architectural components of branches of dendrimers in the development of drug delivery systems based on dendrimer encapsulation properties [ 94 , 95 ]. Several ‘nano-periodic’ property patterns were analyzed related to the generation of dendrimers such as congestion, surface chemistry, size, shape, flexibility and container properties.…”

“…Compared to linear polymers, dendrimers, which are artificial discrete macromolecules, are highly tunable branched spherical macromaterials [ 9 ] constructed with a well-defined and controlled size, shape, molecular weight, and highly monodispersed properties, which provide a high degree of surface functionality [ 10 ]. As shown in Fig.…”